Catheter Precision, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
Catheter Precision, Inc. (VTAK) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of 0.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-03-31
- Catheter Precision, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2025 was 0.10%.
- Catheter Precision, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2023 was -0.20%.
- Catheter Precision, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2022 was -1.30%.
- Catheter Precision, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2020 was 0.10%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.10% 10-K · filed 2026-03-31 | |
| 2023-12-31 | -0.20% 10-K · filed 2024-04-01 | |
| 2022-12-31 | -1.30% 10-K · filed 2024-04-01 | 1.30% 10-K · filed 2023-03-28 |
| 2020-12-31 | 0.10% 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |